Free Trial
TSE:VBV

VBI Vaccines (VBV) Stock Price, News & Analysis

VBI Vaccines logo

About VBI Vaccines Stock (TSE:VBV)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
1,300 shs
Average Volume
3,637 shs
Market Capitalization
C$308.86 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines to address unmet needs in infectious disease and immuno-oncology in Israel and internationally. The company offers Sci-B-Vac, a third-generation hepatitis B vaccine for adults, children, and newborns; and eVLP, a vaccine platform for the design of enveloped virus-like particle vaccines that closely mimic the target virus. It is also developing congenital cytomegalovirus vaccine candidate for infectious disease; and therapeutic glioblastoma multiforme vaccine candidate for immuno-oncology. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016. The company is headquartered in Cambridge, Massachusetts. VBI Vaccines Inc. is a subsidiary of FDS Pharma ASS.

Receive VBV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for VBI Vaccines and its competitors with MarketBeat's FREE daily newsletter.

VBV Stock News Headlines

Silicon Valley Gold Rush
A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.
VBIVQ VBI Vaccines Inc.
VBI Vaccines Inc VBIV
See More Headlines

VBV Stock Analysis - Frequently Asked Questions

Shares of VBV stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Based on aggregate information from My MarketBeat watchlists, some other companies that VBI Vaccines investors own include Adobe (ADBE), Actinium Pharmaceuticals (ATNM), Inovio Pharmaceuticals (INO), Teladoc Health (TDOC), Tesla (TSLA), VBI Vaccines (VBIV) and Altimmune (ALT).

Industry, Sector and Symbol

Stock Exchange
TSE
Industry
Biological Products, Except Diagnostic Substances
Sub-Industry
Pharmaceutical Products
Current Symbol
TSE:VBV
CIK
N/A
Fax
N/A
Employees
22
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$3.36 million
Price / Cash Flow
N/A
Book Value
C$1.01 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
C$308.86 million
Optionable
Not Optionable
Beta
N/A
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (TSE:VBV) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners